Literature DB >> 32550782

Evaluation of Social Anxiety Levels and Related Factors in Psoriasis Patients: A Controlled, Cross-Sectional Study.

Fatma Elif Yildirim1, Sıla Şeremet2, Fatma Şule Afşar2, İrem Yildiz3, Esin İyidoğan4.   

Abstract

INTRODUCTION: Psoriasis patients usually feel shame over their appearance and suffer from poor self-esteem, social anxiety, and avoidance. However, little is known about factors affecting social anxiety levels in these patients. We sought to examine the psychological, as well as disease-related factors which may affect social anxiety levels in psoriasis patients.
METHODS: Our study consisted of 50 psoriasis outpatients and a corresponding 50 age and sex-matched healthy control volunteers who filled out the Liebowitz Social Anxiety Scale (LSAS), the Hospital Anxiety and Depression Scale (HADS), Multidimensional Scale of Perceived Social Support (MSPSS), Ways of coping questionnaire (WCQ) and Eysenck Personality Questionnaire Revised: abbreviated form (EPQR-A). The patients also completed the Dermatology Life Quality Index (DLQI). The extensiveness and severity of the disease were examined by employing the Psoriasis Area and Severity Index (PASI).
RESULTS: Compared with our controls, psoriasis patients displayed significantly higher degrees of social anxiety. Both social fear⁄avoidance subscale scores of LSAS showed a significant correlation to impairment in quality of life (r: 0.373, p: 0.008, r: 0.336, p: 0.018). No appreciable correlation was observable among the PASI and LSAS scores. Regression analysis showed that EPQR-A-extraversion and neuroticism subscale scores had significant influence on LSAS-Social Anxiety scores, accounting for 41.5% of the variance. EPQR-A-extraversion was found to have significant influence on LSAS-Social avoidance scores, accounting for 26.8% of the variance.
CONCLUSION: Our results indicate that psoriasis causes increased levels of social anxiety which is closely related to impaired quality of life. Personality characteristics might contribute considerably in expressing psychosocial morbidity among individuals living with psoriasis. Copyright:
© 2020 Turkish Neuropsychiatric Society.

Entities:  

Keywords:  Psoriasis; personality; social phobia

Year:  2020        PMID: 32550782      PMCID: PMC7285641          DOI: 10.29399/npa.24854

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  19 in total

Review 1.  Psychologic factors in psoriasis: consequences, mechanisms, and interventions.

Authors:  Dónal G Fortune; Helen L Richards; Christopher E M Griffiths
Journal:  Dermatol Clin       Date:  2005-10       Impact factor: 3.478

2.  Relevance of psychosomatic factors in psoriasis: a case-control study.

Authors:  Slavenka Janković; Milena Raznatović; Jelena Marinković; Natasa Maksimović; Janko Janković; Bosiljka Djikanović
Journal:  Acta Derm Venereol       Date:  2009       Impact factor: 4.437

Review 3.  Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments.

Authors:  Evan Rieder; Francisco Tausk
Journal:  Int J Dermatol       Date:  2012-01       Impact factor: 2.736

4.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

5.  Social coping strategies associated with quality of life decrements among psoriasis patients.

Authors:  S R Rapp; C A Cottrell; M R Leary
Journal:  Br J Dermatol       Date:  2001-10       Impact factor: 9.302

6.  Toward a better understanding of social anxiety and depression in psoriasis patients: The role of determinants, mediators, and moderators.

Authors:  Patryk Łakuta; Hanna Przybyła-Basista
Journal:  J Psychosom Res       Date:  2017-01-10       Impact factor: 3.006

7.  Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study.

Authors:  A Finzi; D Colombo; A Caputo; L Andreassi; S Chimenti; G Vena; L Simoni; S Sgarbi; A Giannetti
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-10       Impact factor: 6.166

8.  Patients' strategies for coping with psoriasis.

Authors:  D G Fortune; H L Richards; C J Main; C E M Griffiths
Journal:  Clin Exp Dermatol       Date:  2002-05       Impact factor: 3.470

Review 9.  Depression and quality of life in psoriasis.

Authors:  Abby S Van Voorhees; Richard Fried
Journal:  Postgrad Med       Date:  2009-07       Impact factor: 3.840

Review 10.  Genetic modulation of personality traits: a systematic review of the literature.

Authors:  Martina Balestri; Raffaella Calati; Alessandro Serretti; Diana De Ronchi
Journal:  Int Clin Psychopharmacol       Date:  2014-01       Impact factor: 1.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.